Symptoms of Attention Deficit Hyperactivity Disorder in Children and Adults with Intellectual Disability: A Review

被引:17
作者
Reilly, Colin [1 ]
Holland, Niamh [2 ]
机构
[1] Univ Coll Dublin, Sch Educ, Dublin 4, Ireland
[2] Dept Psychol, Dublin 9, Ireland
关键词
ADHD; intellectual disability; intervention; prevalence; ADHD RATING-SCALES; 4-YEAR FOLLOW-UP; MENTAL-RETARDATION; PSYCHIATRIC-DISORDERS; DEFICIT/HYPERACTIVITY DISORDER; DEVELOPMENTAL-DISABILITIES; FRAGILE-X; METHYLPHENIDATE TREATMENT; PSYCHOMETRIC PROPERTIES; MALADAPTIVE BEHAVIOR;
D O I
10.1111/j.1468-3148.2010.00607.x
中图分类号
G44 [教育心理学];
学科分类号
0402 ; 040202 ;
摘要
Background Despite a reported excess of attention deficit hyperactivity disorder (ADHD) symptoms in individuals with intellectual disability, it has been argued that ADHD symptoms have been under diagnosed and inadequately treated in individuals with intellectual disability. Materials and methods Published studies focussing on the level of ADHD symptoms in children and adults with intellectual disability are reviewed. Issues around screening for ADHD symptoms in individuals with intellectual disability and the validity of the diagnosis of ADHD are considered. Interventions including pharmacological studies are discussed with respect to published research. Results Reported prevalence rates of ADHD symptoms in individuals with intellectual disability vary significantly depending on instruments and diagnostic practices employed. Published research on interventions for individuals with ADHD has primarily focussed on pharmacological interventions. Conclusion Much less is known about ADHD in individuals with intellectual disability than about ADHD in individuals without intellectual disability. There is an urgent need to clarify baseline rates of ADHD in individuals with intellectual disability and to develop efficacious interventions to support affected individuals and their families.
引用
收藏
页码:291 / 309
页数:19
相关论文
共 131 条
[1]  
ABIKOFF H, 1985, PSYCHOPHARMACOL BULL, V21, P901
[2]  
Agarwal V, 2001, MENT RETARD, V39, P259, DOI 10.1352/0047-6765(2001)039<0259:DBPCTO>2.0.CO
[3]  
2
[4]   PSYCHOTROPIC AND ANTICONVULSANT DRUGS IN SUBJECTS WITH AUTISM - PREVALENCE AND PATTERNS OF USE [J].
AMAN, MG ;
VANBOURGONDIEN, ME ;
WOLFORD, PL ;
SARPHARE, G .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1995, 34 (12) :1672-1681
[5]   Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ [J].
Aman, MG ;
Binder, C ;
Turgay, A .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2004, 14 (02) :243-254
[6]   FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL-RETARDATION AND ATTENTION-DEFICIT HYPERACTIVITY DISORDER - LABORATORY EFFECTS [J].
AMAN, MG ;
KERN, RA ;
MCGHEE, DE ;
ARNOLD, LE .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 1993, 23 (03) :491-506
[7]  
Aman MG, 1997, AM J MENT RETARD, V101, P521
[8]   Four-year follow-up of children with low intelligence and ADHD: a replication [J].
Aman, MG ;
Armstrong, S ;
Buican, B ;
Sillick, T .
RESEARCH IN DEVELOPMENTAL DISABILITIES, 2002, 23 (02) :119-134
[10]   CLINICAL EFFECTS OF METHYLPHENIDATE AND THIORIDAZINE IN INTELLECTUALLY SUBAVERAGE CHILDREN [J].
AMAN, MG ;
MARKS, RE ;
TURBOTT, SH ;
WILSHER, CP ;
MERRY, SN .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1991, 30 (02) :246-256